but it doesn’t get the attention it deserves—especially when it comes to skin checks for cancer. That should change, says Dr. Susan Massick, associate professor of dermatology at The Ohio ...

Nov. 19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor ...

While imbalances in skin microbiome composition are linked to disease, studying it ... Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov ... from Puncture Oct. 28, 2024 — Thin ...

If you've been diagnosed with a skin cancer, your physician may have presented you with various treatment options, such as skin cancer excision, Mohs micrographic surgery, cryotherapy, and ...

She serves on the scientific advisory committee for Melanoma and Skin Cancer Advocacy Group. Caitlin Horsham does not work for, consult, own shares in or receive funding from any company or ...

Knowing this helps your doctor decide which treatment you need. Unfortunately, Stage 4 melanoma skin cancer means the cancer is advanced. Treatment aims to control the cancer and help relieve symptoms ...

During a Case-Based Roundtable® event, Hussein A. Tawbi, MD, PhD, and participants look at benefits of nivolumab combinations for brain metastases and PD-L1 positivity in the metastatic melanoma ...

Julian Lennon has been diagnosed with skin cancer for the second time. The musician shared his recent health scare, which resulted in emergency surgery, on social media, reminding fans to ...

Skin cancer remains the most common form of cancer worldwide, often presenting as benign skin conditions that are difficult to differentiate, even for experienced dermatologists. Misdiagnosis can ...

The Breslow thickness describes how deep a melanoma has grown into the layers of skin. Doctors need to know the depth of a melanoma to help stage it. The stage tells you the size of a cancer and if it ...

The FDA has approved cosibelimab, a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer. It is the first and only PD-L1 blocker approved to treat ...

In an ongoing adaptive-design trial exploring different combinations of neoadjuvant immunotherapies including the anti-PD-1 agent pembrolizumab, the anti-TIGIT agent vibostolimab and the oncolytic ...